Transgene Announces Investor Meetings for January 2021
By nh|2020-12-16T16:49:10+01:00December 16th, 2020|Press release|Comments Off on Transgene Announces Investor Meetings for January 2021
About the Author: nh
Related Posts
- First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy
First Head & Neck Cancer Patient Treated in France in a Phase I trial with TG4050 (myvac® Platform), Transgene’s Innovative Individualized Immunotherapy